Hep C may benefit from genetic fingerprinting, research says
Genetic fingerprinting may predict who will benefit from early hepatitis C treatment and who will clear the virus spontaneously, new research shows.
Sep 28, 2010
5 / 5 (1)
0
Sep 28, 2010
5 / 5 (1)
0
Taribavirin offers a safe, effective alternative for chronic hepatitis C
Researchers at Cedars-Sinai Medical Center and 50 other centers found that weight-based dosing of taribavirin reduces rates of anemia while increasing sustained virologic response (SVR) in patients with chronic hepatitis ...
Sep 22, 2010
5 / 5 (1)
0
Scientists identify key interaction in hepatitis C virus
Scientists from the Florida campus of The Scripps Research Institute have identified a molecular interaction between a structural hepatitis C virus protein (HCV) and a protein critical to viral replication. This new finding ...
Dec 29, 2010
not rated yet
0
Hepatitis C study shows superior viral cure rate
For patients with the most common form of hepatitis C being treated for the first time, the addition of an investigational hepatitis C–specific protease inhibitor called telaprevir to the current standard therapy markedly ...
Nov 02, 2010
not rated yet
0
Researchers find function of proteins that can enhance the progression of viruses and cancer cells
In a discovery that has implications for developing treatments against cancer and potentially deadly viruses, researchers at SUNY Downstate Medical Center have discovered the function of proteins that can enhance the progression ...
Aug 16, 2010
5 / 5 (2)
0
Study examines risk of heterosexual HIV transmission in China
A new study by researchers at the Johns Hopkins Bloomberg School of Public Health examines the burden of HIV and sexually transmitted disease among male clients of the commercial sex industry in China's Sichuan province. ...
Nov 08, 2010
not rated yet
0
Lack of health insurance limits hepatitis C patients' access to latest antiviral therapy
New research has determined that patients in the U.S. with hepatitis C virus (HCV) are twice as likely to not have health insurance coverage compared with those without the disease. In fact researchers found only a third ...
Feb 24, 2011
not rated yet
0
Quadruple therapy shows 100 percent SVR for HCV patients previously unresponsive to treatment
Berlin, Germany, Saturday 02 April 2011: Exciting new data presented today at the International Liver CongressTM 2011 show that quadruple therapy in chronic hepatitis C (HCV) patients suppressed the emergence of resistant ...
Apr 02, 2011
not rated yet
0
Data suggest liver experts should take care when prescribing novel antiviral HCV drugs
Data presented at the International Liver Congress highlight the fact that new novel antiviral compounds for the treatment of hepatitis C virus (HCV) must be prescribed and monitored by experts and specialists to ensure resistance ...
Apr 02, 2011
not rated yet
0
FDA says Vertex hepatitis drug is highly effective
(AP) -- Federal health officials say a highly anticipated hepatitis C drug from Vertex Pharmaceuticals successfully treats a clear majority of patients in less time than older medicines that have been used for 20 years.
Apr 26, 2011
not rated yet
1
Research suggests HIV-infected patients at higher risk for bone fractures
Low bone mineral density in HIV-infected patients is common and raises concerns about increased risks of fracture. Although there have been several studies regarding bone mineral density, there have been few data on rates ...
Mar 11, 2011
not rated yet
0
The future looks bright for HCV patients who have failed to respond to current treatments
Berlin, Germany, Friday 1st April 2011: Highly anticipated data from a number of clinical trials presented for the first time at the International Liver CongressTM confirmed that a range of new proteases inhibitors will help ...
Apr 01, 2011
5 / 5 (1)
0
IL28B gene predicts treatment outcome for liver transplantation patients
German researchers have found a significant association of IL28B genotypes to interferon-based antiviral treatment outcome, and to graft inflammation caused by hepatitis C virus (HCV). The study determined that the presence ...
Mar 02, 2011
not rated yet
0
The relationship between body mass index and age at hepatocellular carcinoma onset
A research team from Japan identified factors associated with the age at onset of hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC). The results showed that increased body mass index (BMI) is associated with ...
Mar 15, 2011
5 / 5 (1)
0
Drug use increasingly associated with microbial infections
Illicit drug users are at increased risk of being exposed to microbial pathogens and are more susceptible to serious infections say physicians writing in the Journal of Medical Microbiology. The review, which aims to imp ...
Mar 10, 2011
not rated yet
0
